Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-Chloroethyl-6-chloro-1,3-dihydro-2H-indole-2-one, also known as 6-Chloro-5-(2-chloroethyl)oxindole (CAS# 118289-55-7), is an organic compound with significant utility in various fields of chemical and pharmaceutical research. It is characterized by its pale pink solid appearance and is recognized for its unique chemical properties that make it a valuable component in organic synthesis.

118289-55-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 118289-55-7 Structure
  • Basic information

    1. Product Name: 5-Chloroethyl-6-chloro-1,3-dihydro-2H-indole-2-one
    2. Synonyms: 2H-INDOLE-2-ONE,5-CHLOROETHYL-6-CHLORO-1,3-DIHYDRO;5-CHLOROETHYL-6-CHLORO-1,3-DIHYDRO-1H-INDOL-2-ONE;5-CHLOROETHYL-6-CHLORO-1,3-DIHYDRO-2H-INDOLE-2-ONE;6-CHLORO-5-(2-CHLOROETHYL)-1,3-DIHYDRO-2H-INDOL-2-ONE;5-(2-CHLOROETHYL)-1,3-DIHYDRO-2H-6-CHLOROINDULE-2-ONE;2H-Indol-2-one-6-chloro-5-(2-chloroethyl)-1,3-dihydro;5-Chloroethyl-6-chloro-1,3-dihydro-2H-indol-2-one;6-Chloro-5-(2-Chloroethyl)-1,3
    3. CAS NO:118289-55-7
    4. Molecular Formula: C10H9Cl2NO
    5. Molecular Weight: 230.09
    6. EINECS: 421-320-0
    7. Product Categories: Indole;Indoles;(intermediate of ziprasidone hcl);Intermediates of Ziprasidone;Intermediates & Fine Chemicals;Pharmaceuticals
    8. Mol File: 118289-55-7.mol
  • Chemical Properties

    1. Melting Point: 218-221℃
    2. Boiling Point: 393.82 °C at 760 mmHg
    3. Flash Point: 191.976 °C
    4. Appearance: /
    5. Density: 1.376 g/cm3
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.592
    8. Storage Temp.: Refrigerator
    9. Solubility: soluble in Dimethylformamide
    10. PKA: 13.23±0.20(Predicted)
    11. CAS DataBase Reference: 5-Chloroethyl-6-chloro-1,3-dihydro-2H-indole-2-one(CAS DataBase Reference)
    12. NIST Chemistry Reference: 5-Chloroethyl-6-chloro-1,3-dihydro-2H-indole-2-one(118289-55-7)
    13. EPA Substance Registry System: 5-Chloroethyl-6-chloro-1,3-dihydro-2H-indole-2-one(118289-55-7)
  • Safety Data

    1. Hazard Codes: N
    2. Statements: 50/53
    3. Safety Statements: 60-61-24/25
    4. RIDADR: 3077
    5. WGK Germany:
    6. RTECS:
    7. HazardClass: 9
    8. PackingGroup: III
    9. Hazardous Substances Data: 118289-55-7(Hazardous Substances Data)

118289-55-7 Usage

Uses

Used in Organic Synthesis:
5-Chloroethyl-6-chloro-1,3-dihydro-2H-indole-2-one is used as a key intermediate in the synthesis of various organic compounds. Its unique structure allows for the creation of a wide range of molecules with diverse applications in different industries.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 5-Chloroethyl-6-chloro-1,3-dihydro-2H-indole-2-one is used as a building block for the development of new drugs. Its chemical properties make it a promising candidate for the creation of novel therapeutic agents, particularly in the areas of cancer treatment and other medical conditions.
Used in Chemical Research:
5-Chloroethyl-6-chloro-1,3-dihydro-2H-indole-2-one is also utilized in chemical research to study the properties and behavior of similar compounds. This helps scientists understand the underlying mechanisms and interactions of these molecules, which can lead to the discovery of new applications and uses.

Check Digit Verification of cas no

The CAS Registry Mumber 118289-55-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,8,2,8 and 9 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 118289-55:
(8*1)+(7*1)+(6*8)+(5*2)+(4*8)+(3*9)+(2*5)+(1*5)=147
147 % 10 = 7
So 118289-55-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H9Cl2NO/c11-2-1-6-3-7-4-10(14)13-9(7)5-8(6)12/h3,5H,1-2,4H2,(H,13,14)

118289-55-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Chloroethyl-6-Chloro-1,3-Dihydro-2H-Indole-2-One

1.2 Other means of identification

Product number -
Other names 5-Chloroethyl-6-chloro-1,3-dihydro-2H-indole-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:118289-55-7 SDS

118289-55-7Synthetic route

6-chloro-5-(2-hydroxyethyl)-2-oxindole

6-chloro-5-(2-hydroxyethyl)-2-oxindole

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
With triphenylphosphine In tetrahydrofuran; tetrachloromethane for 3h; Reflux;97%
C17H16ClNO4S

C17H16ClNO4S

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
With lithium chloride In N,N-dimethyl-formamide at 50℃; for 8h;95%
6-chloro-5-(2-chloroacetyl) indolin-2-one
118307-04-3

6-chloro-5-(2-chloroacetyl) indolin-2-one

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
With triethylsilane; trifluoroacetic acid
Stage #1: 6-chloro-5-(2-chloroacetyl) indolin-2-one With triethylsilane; trifluoroacetic acid at 0 - 35℃; for 7h;
Stage #2: With water at 5 - 10℃; for 1h;
With triethylsilane In trifluoroacetic acid at -5 - 45℃; for 7.5h;
6-chloro-2-oxindole
56341-37-8

6-chloro-2-oxindole

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: AlCl3 / CS2
2: Et3SiH, CF3COOH
View Scheme
Multi-step reaction with 2 steps
1.1: aluminum (III) chloride / 1,2-dichloro-ethane / 20 °C / Inert atmosphere
1.2: 35 - 37 °C / Inert atmosphere
2.1: trifluoroacetic acid / 0.25 h / 25 - 30 °C / Inert atmosphere
2.2: 0 - 35 °C / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1: aluminum (III) chloride / dichloromethane / 20 h / Reflux; Inert atmosphere
2: aluminum (III) chloride; 1,1,3,3-Tetramethyldisiloxane / dichloromethane / 0 °C / Inert atmosphere
View Scheme
6-chloro-5-(2-chloroacetyl) indolin-2-one
118307-04-3

6-chloro-5-(2-chloroacetyl) indolin-2-one

A

6-chloro-5-(2-chloro-1-hydroxyethyl) indolin-2-one
884305-06-0

6-chloro-5-(2-chloro-1-hydroxyethyl) indolin-2-one

B

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
With triethylsilane; trifluoroacetic acid for 7h;
With aluminum (III) chloride; 1,1,3,3-Tetramethyldisiloxane In dichloromethane at 0℃; Inert atmosphere; chemoselective reaction;
6-chloro-5-(2-chloro-1-hydroxyethyl) indolin-2-one
884305-06-0

6-chloro-5-(2-chloro-1-hydroxyethyl) indolin-2-one

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
Stage #1: 6-chloro-5-(2-chloro-1-hydroxyethyl) indolin-2-one With trifluoroacetic acid at 20℃; for 1h;
Stage #2: With triethylsilane at 35 - 40℃; for 13.5 - 15.5h;
Stage #1: 6-chloro-5-(2-chloro-1-hydroxyethyl) indolin-2-one With trifluoroacetic acid at 20℃; for 1h;
Stage #2: With triethylsilane at 35 - 40℃; for 13.5 - 15.5h;
2,5-dichloronitrobenzene
89-61-2

2,5-dichloronitrobenzene

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: potassium carbonate / dimethyl sulfoxide / 25 - 30 °C / Inert atmosphere
1.2: 16 h / 40 - 85 °C
2.1: hydrogenchloride; tin / water; methanol / 10 - 70 °C
3.1: aluminum (III) chloride / 1,2-dichloro-ethane / 20 °C / Inert atmosphere
3.2: 35 - 37 °C / Inert atmosphere
4.1: trifluoroacetic acid / 0.25 h / 25 - 30 °C / Inert atmosphere
4.2: 0 - 35 °C / Inert atmosphere
View Scheme
dimethyl (4-chloro-2-nitrophenyl)malonate
147124-32-1

dimethyl (4-chloro-2-nitrophenyl)malonate

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: hydrogenchloride; tin / water; methanol / 10 - 70 °C
2.1: aluminum (III) chloride / 1,2-dichloro-ethane / 20 °C / Inert atmosphere
2.2: 35 - 37 °C / Inert atmosphere
3.1: trifluoroacetic acid / 0.25 h / 25 - 30 °C / Inert atmosphere
3.2: 0 - 35 °C / Inert atmosphere
View Scheme
6-chloro-5-(2-chloroacetyl) indolin-2-one
118307-04-3

6-chloro-5-(2-chloroacetyl) indolin-2-one

A

6-chloro-5-(2-chloro-1-hydroxyethyl) indolin-2-one
884305-06-0

6-chloro-5-(2-chloro-1-hydroxyethyl) indolin-2-one

B

6-chloro-5-ethylindolin-2-one

6-chloro-5-ethylindolin-2-one

C

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
With triethylsilane; aluminum (III) chloride In dichloromethane at 0 - 20℃; for 12h; Inert atmosphere; Reflux;
6-chloro-5-(2-chloroacetyl) indolin-2-one
118307-04-3

6-chloro-5-(2-chloroacetyl) indolin-2-one

A

6-chloro-5-ethylindolin-2-one

6-chloro-5-ethylindolin-2-one

B

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
With aluminum (III) chloride; dimethylmonochlorosilane In dichloromethane at 0℃; Inert atmosphere; chemoselective reaction;
6-chloro-2-oxindole
56341-37-8

6-chloro-2-oxindole

A

6-chloro-5-(2-chloro-1-hydroxyethyl) indolin-2-one
884305-06-0

6-chloro-5-(2-chloro-1-hydroxyethyl) indolin-2-one

B

6-chloro-5-ethylindolin-2-one

6-chloro-5-ethylindolin-2-one

C

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aluminum (III) chloride / dichloromethane / 20 h / Reflux; Inert atmosphere
2: aluminum (III) chloride; triethylsilane / dichloromethane / 12 h / 0 - 20 °C / Inert atmosphere; Reflux
View Scheme
6-chloro-2-oxindole
56341-37-8

6-chloro-2-oxindole

A

6-chloro-5-(2-chloro-1-hydroxyethyl) indolin-2-one
884305-06-0

6-chloro-5-(2-chloro-1-hydroxyethyl) indolin-2-one

B

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: aluminum (III) chloride / dichloromethane / 20 h / Reflux; Inert atmosphere
2: aluminum (III) chloride; 1,1,3,3-Tetramethyldisiloxane / dichloromethane / 0 °C / Inert atmosphere
View Scheme
5-chloro-2,4-difluoronitrobenzene
1481-68-1

5-chloro-2,4-difluoronitrobenzene

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: N,N-dimethyl-formamide / 12 h / 100 °C
2: hydrogenchloride; acetic acid / water / 18 h / Reflux
3: thionyl chloride / 4 h / 20 °C
4: acetic acid; hydrogen / 3 h / 20 °C / 2327.23 Torr
5: sodium tetrahydroborate; lithium bromide; Trimethyl borate / tetrahydrofuran / 18 h / Reflux
6: triphenylphosphine / tetrahydrofuran; tetrachloromethane / 3 h / Reflux
View Scheme
Multi-step reaction with 7 steps
1: N,N-dimethyl-formamide / 12 h / 100 °C
2: hydrogenchloride; acetic acid / water / 18 h / Reflux
3: thionyl chloride / 4 h / 20 °C
4: acetic acid; hydrogen / 3 h / 20 °C / 2327.23 Torr
5: sodium tetrahydroborate; lithium bromide; Trimethyl borate / tetrahydrofuran / 18 h / Reflux
6: triethylamine; dmap / dichloromethane / 5 h / Reflux
7: lithium chloride / N,N-dimethyl-formamide / 8 h / 50 °C
View Scheme
tetraethyl 4-chloro-6-nitro-1,3-benzenedimalonate

tetraethyl 4-chloro-6-nitro-1,3-benzenedimalonate

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: hydrogenchloride; acetic acid / water / 18 h / Reflux
2: thionyl chloride / 4 h / 20 °C
3: acetic acid; hydrogen / 3 h / 20 °C / 2327.23 Torr
4: sodium tetrahydroborate; lithium bromide; Trimethyl borate / tetrahydrofuran / 18 h / Reflux
5: triphenylphosphine / tetrahydrofuran; tetrachloromethane / 3 h / Reflux
View Scheme
Multi-step reaction with 6 steps
1: hydrogenchloride; acetic acid / water / 18 h / Reflux
2: thionyl chloride / 4 h / 20 °C
3: acetic acid; hydrogen / 3 h / 20 °C / 2327.23 Torr
4: sodium tetrahydroborate; lithium bromide; Trimethyl borate / tetrahydrofuran / 18 h / Reflux
5: triethylamine; dmap / dichloromethane / 5 h / Reflux
6: lithium chloride / N,N-dimethyl-formamide / 8 h / 50 °C
View Scheme
4-chloro-6-nitro-1,3-benzenediacetic acid

4-chloro-6-nitro-1,3-benzenediacetic acid

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: thionyl chloride / 4 h / 20 °C
2: acetic acid; hydrogen / 3 h / 20 °C / 2327.23 Torr
3: sodium tetrahydroborate; lithium bromide; Trimethyl borate / tetrahydrofuran / 18 h / Reflux
4: triphenylphosphine / tetrahydrofuran; tetrachloromethane / 3 h / Reflux
View Scheme
Multi-step reaction with 5 steps
1: thionyl chloride / 4 h / 20 °C
2: acetic acid; hydrogen / 3 h / 20 °C / 2327.23 Torr
3: sodium tetrahydroborate; lithium bromide; Trimethyl borate / tetrahydrofuran / 18 h / Reflux
4: triethylamine; dmap / dichloromethane / 5 h / Reflux
5: lithium chloride / N,N-dimethyl-formamide / 8 h / 50 °C
View Scheme
dimethyl 4-chloro-6-nitro-1,3-benzenediacetate

dimethyl 4-chloro-6-nitro-1,3-benzenediacetate

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: acetic acid; hydrogen / 3 h / 20 °C / 2327.23 Torr
2: sodium tetrahydroborate; lithium bromide; Trimethyl borate / tetrahydrofuran / 18 h / Reflux
3: triphenylphosphine / tetrahydrofuran; tetrachloromethane / 3 h / Reflux
View Scheme
Multi-step reaction with 4 steps
1: acetic acid; hydrogen / 3 h / 20 °C / 2327.23 Torr
2: sodium tetrahydroborate; lithium bromide; Trimethyl borate / tetrahydrofuran / 18 h / Reflux
3: triethylamine; dmap / dichloromethane / 5 h / Reflux
4: lithium chloride / N,N-dimethyl-formamide / 8 h / 50 °C
View Scheme
methyl 6-chloro-(2-oxindol-5-yl)acetate

methyl 6-chloro-(2-oxindol-5-yl)acetate

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium tetrahydroborate; lithium bromide; Trimethyl borate / tetrahydrofuran / 18 h / Reflux
2: triphenylphosphine / tetrahydrofuran; tetrachloromethane / 3 h / Reflux
View Scheme
Multi-step reaction with 3 steps
1: sodium tetrahydroborate; lithium bromide; Trimethyl borate / tetrahydrofuran / 18 h / Reflux
2: triethylamine; dmap / dichloromethane / 5 h / Reflux
3: lithium chloride / N,N-dimethyl-formamide / 8 h / 50 °C
View Scheme
2,4,5-Trichloronitrobenzene
89-69-0

2,4,5-Trichloronitrobenzene

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: potassium fluoride / N,N-dimethyl-formamide / 12 h / 125 °C / Inert atmosphere
2: N,N-dimethyl-formamide / 12 h / 100 °C
3: hydrogenchloride; acetic acid / water / 18 h / Reflux
4: thionyl chloride / 4 h / 20 °C
5: acetic acid; hydrogen / 3 h / 20 °C / 2327.23 Torr
6: sodium tetrahydroborate; lithium bromide; Trimethyl borate / tetrahydrofuran / 18 h / Reflux
7: triphenylphosphine / tetrahydrofuran; tetrachloromethane / 3 h / Reflux
View Scheme
Multi-step reaction with 8 steps
1: potassium fluoride / N,N-dimethyl-formamide / 12 h / 125 °C / Inert atmosphere
2: N,N-dimethyl-formamide / 12 h / 100 °C
3: hydrogenchloride; acetic acid / water / 18 h / Reflux
4: thionyl chloride / 4 h / 20 °C
5: acetic acid; hydrogen / 3 h / 20 °C / 2327.23 Torr
6: sodium tetrahydroborate; lithium bromide; Trimethyl borate / tetrahydrofuran / 18 h / Reflux
7: triethylamine; dmap / dichloromethane / 5 h / Reflux
8: lithium chloride / N,N-dimethyl-formamide / 8 h / 50 °C
View Scheme
3-(1-piperazinyl)-1,2-benzisothiazole
87691-87-0

3-(1-piperazinyl)-1,2-benzisothiazole

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
With Morwet D425 In water Reflux; Inert atmosphere;92%
In water Inert atmosphere; Reflux; dispersing agent;92%
With potassium carbonate; potassium iodide In sulfolane at 75 - 100℃; for 2h; Product distribution / selectivity;75%
3-(1-piperazinyl)-1,2-benzoisothiazole hydrochloride

3-(1-piperazinyl)-1,2-benzoisothiazole hydrochloride

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
With Morwet D425 In water Product distribution / selectivity; Reflux; Inert atmosphere;92%
With sodium carbonate In water Product distribution / selectivity; Inert atmosphere; Reflux; Morwet D425;90%
Stage #1: 3-(piperazin-1-yl)-1,2-benzisothiazole hydrochloride With potassium carbonate In acetonitrile for 0.5h;
Stage #2: 6-chloro-5-(2-chloroethyl)-2-oxindole With sodium iodide In acetonitrile for 2h; Reflux;
767 g
6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

7-bromo-3-piperazinyl-1,2-benzisothiazole
155167-98-9

7-bromo-3-piperazinyl-1,2-benzisothiazole

5-(2-(4-(7-bromo-1,2-benzisothiazol-3-yl)piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
155167-99-0

5-(2-(4-(7-bromo-1,2-benzisothiazol-3-yl)piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one

Conditions
ConditionsYield
With sodium carbonate In water at 115℃; for 20h;89%
3-(1-piperazinyl)-1,2-benzisothiazole hydrochloride
87691-88-1

3-(1-piperazinyl)-1,2-benzisothiazole hydrochloride

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
With sodium carbonate In 1-methyl-pyrrolidin-2-one at 130 - 135℃; for 24h; Product distribution / selectivity;88.2%
With sodium carbonate In poly(ethylene glycol) methyl ether at 120 - 125℃; for 48h; Product distribution / selectivity;88%
With sodium carbonate; sodium iodide In toluene for 22.5h; Product distribution / selectivity; Heating / reflux;86%
4-(benzo[b]thiophen-4-yl)piperidine trifluoroacetate

4-(benzo[b]thiophen-4-yl)piperidine trifluoroacetate

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

5-(2-(4-(benzo[b]thiophen-4-yl)piperidin-1-yl)ethyl)-6-chloroindolin-2-one

5-(2-(4-(benzo[b]thiophen-4-yl)piperidin-1-yl)ethyl)-6-chloroindolin-2-one

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In water at 105℃; for 12h;58%
1-(2,3-dihydrobenzo[b]thiophen-4-yl)piperazine hydrochloride

1-(2,3-dihydrobenzo[b]thiophen-4-yl)piperazine hydrochloride

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

6-chloro-5-(2-(4-(2,3-dihydrobenzo[b]thiophen-4-yl)piperazin-1-yl)ethyl)indolin-2-one

6-chloro-5-(2-(4-(2,3-dihydrobenzo[b]thiophen-4-yl)piperazin-1-yl)ethyl)indolin-2-one

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In acetonitrile at 85℃;56%
1-(benzo[b]thiophen-4-yl)piperazine hydrochloride

1-(benzo[b]thiophen-4-yl)piperazine hydrochloride

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

5-(2-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride

5-(2-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride

Conditions
ConditionsYield
With sodium carbonate; sodium iodide In water for 24h; Reflux;51%
4-(piperazin-1-yl)thieno[2,3-c]pyridine trifluoroacetate

4-(piperazin-1-yl)thieno[2,3-c]pyridine trifluoroacetate

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

6-chloro-5-(2-(4-(thieno[2,3-c]pyridin-4-yl)piperazin-1-yl)ethyl)indolin-2-one

6-chloro-5-(2-(4-(thieno[2,3-c]pyridin-4-yl)piperazin-1-yl)ethyl)indolin-2-one

Conditions
ConditionsYield
With potassium carbonate; potassium iodide In acetonitrile at 80℃;8.7%
3-(1-piperazinyl)-1,2-benzisothiazole
87691-87-0

3-(1-piperazinyl)-1,2-benzisothiazole

acetone
67-64-1

acetone

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

5-[2-(4-1,2-benzisothiazol-3-yl-piperazin-1-yl)ethyl]-6-chloro-3-isopropylidene-1,3-dihydro-indol-2-one

5-[2-(4-1,2-benzisothiazol-3-yl-piperazin-1-yl)ethyl]-6-chloro-3-isopropylidene-1,3-dihydro-indol-2-one

Conditions
ConditionsYield
With potassium carbonate In water at 100℃; for 24h; Heating / reflux;3%
6-chloro-5-(2-chloro-1-hydroxyethyl) indolin-2-one
884305-06-0

6-chloro-5-(2-chloro-1-hydroxyethyl) indolin-2-one

3-(1-piperazinyl)-1,2-benzisothiazole
87691-87-0

3-(1-piperazinyl)-1,2-benzisothiazole

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

6-chloro-5-(2-chloroacetyl) indolin-2-one
118307-04-3

6-chloro-5-(2-chloroacetyl) indolin-2-one

A

5-(2-(4-(1,2-benzisothiazole-3-yl)-1-piperazinyl)-1-hydroxyethyl)-6-chloro-1,3-dihydro-2H-indole-2-one
884305-08-2

5-(2-(4-(1,2-benzisothiazole-3-yl)-1-piperazinyl)-1-hydroxyethyl)-6-chloro-1,3-dihydro-2H-indole-2-one

B

5-(2-(4-(1,2-benzisothiazole-3-yl)-1-piperazinyl)-1-oxoethyl)-6-chloro-1,3-dihydro-2H-indole-2-one
884305-07-1

5-(2-(4-(1,2-benzisothiazole-3-yl)-1-piperazinyl)-1-oxoethyl)-6-chloro-1,3-dihydro-2H-indole-2-one

Conditions
ConditionsYield
With tetrabutylammomium bromide; sodium carbonate; sodium iodide In cyclohexane Heating / reflux;
4-trimethylsilyl-1-(benzo[d]isothiazol-3-yl)piperazine

4-trimethylsilyl-1-(benzo[d]isothiazol-3-yl)piperazine

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

Conditions
ConditionsYield
With water; sodium carbonate; sodium iodide In N,N-dimethyl-formamide at 110℃; for 0.5h; Product distribution / selectivity;
With water; sodium carbonate; sodium iodide at 95 - 100℃; for 7.66667h; Product distribution / selectivity;
3-(1-piperazinyl)-1,2-benzisothiazole
87691-87-0

3-(1-piperazinyl)-1,2-benzisothiazole

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

ziprasidone hydrochloride

ziprasidone hydrochloride

Conditions
ConditionsYield
Stage #1: 3-(1-piperazinyl)-1,2-benzisothiazole; 6-chloro-5-(2-chloroethyl)-2-oxindole With sodium carbonate; sodium iodide In water; dimethyl sulfoxide at 115 - 125℃; for 2.75h;
Stage #2: With hydrogenchloride In water for 0.166667h;
1-(benzo[d]isoxazol-3-yl)piperazine hydrochloride
87691-90-5

1-(benzo[d]isoxazol-3-yl)piperazine hydrochloride

6-chloro-5-(2-chloroethyl)-2-oxindole
118289-55-7

6-chloro-5-(2-chloroethyl)-2-oxindole

5-(2-(4-(1,2-benziso-thiazol-3-yl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one

5-(2-(4-(1,2-benziso-thiazol-3-yl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one

Conditions
ConditionsYield
Stage #1: 1-(benzo[d]isoxazol-3-yl)piperazine hydrochloride With sodium carbonate In water at 20℃; for 1h;
Stage #2: 6-chloro-5-(2-chloroethyl)-2-oxindole With sodium iodide In water at 20 - 90℃; for 21 - 31h;
Stage #3: In water at 45 - 80℃; for 1h; Product distribution / selectivity;

118289-55-7Relevant articles and documents

Improved process for the preparation of 6-chloro-5-(2-chloroethyl)oxindole

Nadkarni, Durgesh V.,Hallissey, James F.

, p. 1142 - 1145 (2008)

The current process for ziprasidone involves preparation and isolation of the key intermediate 6-chloro-5-(2-chloroethyl)oxindole. An improved process for the synthesis of this intermediate is reported here. The new process involves use of a novel Lewis acid-mediated selective deoxygenation of the precursor ketone with tetramethyldisiloxane. The new method affords the desired compound in a one-pot process obviating the need for isolation of the potentially hazardous precursor ketone. This process was successfully scaled up to multikilo scale.

A SHORT PROCESS FOR THE PREPARATION OF ZIPRASIDONE AND INTERMEDIATES THEREOF

-

Page/Page column 14, (2012/03/09)

A process for the preparation of oxindole derivative (Ziprasidone hydrochloride) of formula (I) comprising reacting compound of formula (II) with metal or metal compound mineral acid to give compound of formula (III) in a single step which is converted into compound of formula IV which is a key intermediate for the preparation of compound of compound of formula (I).

Process for the preparation of ziprasidone

-

Page/Page column 3, (2008/06/13)

A process for the preparation of ziprasidone and a novel intermediate useful in its preparation. The process comprises the reduction of a compound (III) to give a compound (V) which is then reduced to compound (II). This is reacted with compound (IV) to give the desired compound.

A process for the preparation of ziprasidone

-

Page/Page column title page; 5, (2008/06/13)

A process for the preparation of ziprasidone and a novel intermediate useful in its preparation. The process comprises the reduction of a compound (III) to give a compound (V) which is then reduced to compound (II). This is reacted with compound (IV) to give the desired compound.

Ziprasidone process

-

Page/Page column 7, (2008/06/13)

A process for preparing ziprasidone having low levels of keto ziprasidone and hydroxy ziprasidone impurities.

Process for the preparation of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1piperazinyl) ethyl)-6-chloro-1, 3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride) and its intermediate

-

Page 5-6, (2008/06/13)

The present invention relates to improved processes for the preparation of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl) ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one and its hydrochloride, which is known as Ziprasidone hydrochloride of Formula (I) and 5-(2-Chloro acetyl)-6-chloro oxindole of Formula (IV), which is an intermediate for the preparation of 5-(2-chloro ethyl)-6-chloro oxindole of Formula (V). Ziprasidone hydrochloride of Formula (I) of the present invention is depicted by the following structure.

POLYMORPHIC FORMS OF ZIPRASIDONE AND ITS HYDROCHLORIDE

-

Page 12, (2008/06/13)

The present invention is related to crystalline forms of ziprasidone and its hydrochloride salt and an amorphous form of ziprasidone hydrochloride and the process for the preparation thereof. The crystalline forms and amorphous form of the invention are suitable for pharmaceutical purposes in the treatment of psychosis. The processes of the invention are simple, non-hazardous and commercially suitable.

A PROCESS FOR THE PREPARATION OF OXINDOLE DERIVATIVES

-

Page 13, (2008/06/13)

A process for the preparation of oxindole derivative of formula (I) comprising reacting compound of formula (II) with dialkyl malonate, COOR1-COOR1, in the presence of a mild base to give compound of formula (III); and wherein R is selected from hydrogen, linear, branched or cyclic alkyl, aryl, substituted aryl, heteroaryl, haloalkyl like CF3, alkoxy, haloalkoxy, thioalkyl and halogen.; R1 is selected from linear, branched and cyclic alkyl (C1 to C4 groups); and X is selected from chloro, bromo, fluoro and iodo groups;further converting compound of formula (III) to compound of formula (I).

A new route to prepare 6-chloro-5-(2-chloroethyl)oxindole

Gurjar, Mukund K.,Murugaiah,Reddy, Dandepally Srinivasa,Chorghade, Mukund S.

, p. 309 - 312 (2013/09/06)

6-Chloro-5-(2-chloroethyl)oxindole, a key intermediate in the manufacturing of the antipsychotic drug, ziprasidone, has been synthesized by a new route. The salient features of the synthesis are (1) bis-dialkylation of 2,4-difluoro-5-chloronitrobenzene with sodium diethyl malonate, (2) decarboxylative hydrolysis to obtain the oxindole derivative, and (3) reduction and chlorination of acetic ester side chain.

Method of treating psychiatric conditions

-

, (2008/06/13)

A method for treating a psychiatic condition or disorder selected from anxiety disorders such as panic disorder, posttraumatic stress disorder and phobias, psychotic episodes of anxiety, anxiety associated with psychosis, psychotic mood disorders such as severe major depressive disorder and mood disorders associated with psychotic disorders such as acute mania or depression associated with bipolar disorder, schizophrenia, behavioral manifestations of mental retardation, conduct disorder or autistic disorder, dementias such as dementias of the Alzheimer's type, and dyskinesias such as drug induced and neurodegeneration based dyskinesias in a mammal, including a human, comprising administering to said mammal a pharmaceutically effective amount of a compound of the formula or a pharmaceutically acceptable acid addition salt thereof, wherein n, X, Y and Ar are as defined above.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 118289-55-7